Disposition of 15994 shares by Kaushal Mohit of Oncology Institute at 2.131 subject to Rule 16b-3
| TOIIW Stock | USD 0.02 0 25.00% |
Slightly above 55% of Oncology Institute's sophisticated investors are presently thinking to get in. The analysis of overall sentiment of trading The Oncology Institute stock suggests that some investors are interested at this time. Oncology Institute's investing sentiment can be driven by a variety of factors including economic data, Oncology Institute's earnings reports, geopolitical events, and overall market trends.
Oncology |
Filed transaction by The Oncology Institute Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Oncology Institute Fundamental Analysis
We analyze Oncology Institute's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oncology Institute using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oncology Institute based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Oncology Institute is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
The Oncology Institute Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oncology Institute stock to make a market-neutral strategy. Peer analysis of Oncology Institute could also be used in its relative valuation, which is a method of valuing Oncology Institute by comparing valuation metrics with similar companies.
Peers
Oncology Institute Related Equities
| TOI | Oncology Institute | 12.24 | ||||
| TALKW | Talkspace | 6.67 |
Additional Tools for Oncology Stock Analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.